Work

[18F]FDG Metabolic Tumor Volume as a Prognostic Marker in Neuroendocrine Neoplasm: A Multicenter Study

Year: 2025

Type: article

Study design: Observational Study

Source: Journal of Nuclear Medicine

DOI: 10.2967/jnumed.124.269031

Authors: David L. Chan, Aimee Hayes, Ioannis Karfis, Alice Conner, Magdalena Mileva, Elizabeth Bernard, Shaunak Navalkissoor, Gopinath Gnanasekaran, Stephen J. Clarke, Paul J. Roach, Patrick Flamen, Martyn E. Caplin, Nick Pavlakis, Christos Toumpanakis, Dale L. Bailey

Institutions: The University of Sydney, Royal North Shore Hospital, The Royal Free Hospital, Université Libre de Bruxelles, Institut Jules Bordet

Language: English

Topic: Neuroendocrine Tumor Research Advances

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410613447

FWCI: 1.869

Cites: 19

Cited by: 3

Related to: 10